ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01ED05 | B | Lorlatinib - 100mg | 10035/945 | 90519/1 | LORBRENA | 100mg | 30 | Tablet | Oral | Droguerie Fattal S.A.L. | Pfizer Pharmaceuticals LLC | USA | 403,677,371 L.L | 2.44 | E2 | Pfizer Inc | USA | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01ED05 | B | Lorlatinib - 100mg | 10035 | 90519/1 | LORBRENA | 100mg | 30 | Tablet | Oral | Droguerie Fattal S.A.L. | Pfizer Pharmaceuticals LLC | USA | 6,621,291 L.L | 2.44 | E2 | Pfizer Inc | USA | 2/5/2024 |